FIELD: chemistry.
SUBSTANCE: invention relates to new compounds of general formula
containing two cyclic groups, especially where M1 - Ring 1 and M2 - Ring 2, each independently represents a phenoxy group. The compounds have high antagonistic activity against human S1P2.
EFFECT: invention due to its properties can be used as a therapeutic agent for the treatment of S1P2-mediated diseases such as diseases, resulting from vasoconstriction, fibrosis and respiratory diseases.
8 cl, 6 dwg, 5 tbl, 45 ex
Title | Year | Author | Number |
---|---|---|---|
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND MEDICAMENTS THEREOF AS ACTIVE INGREDIENT | 2004 |
|
RU2366655C2 |
DERIVATIVES OF CARBOXYLIC ACIDS AND PHARMACEUTICAL AGENT COMPRISING THEIR AS ACTIVE COMPONENT | 2002 |
|
RU2315746C2 |
INDOLE COMPOUND AND USE THEREOF | 2006 |
|
RU2416601C2 |
CARBOXYLIC ACID COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHOD OF TREATMENT, AND APPLICATION | 2004 |
|
RU2335490C2 |
PIPERIDINE DERIVATIVES AND AGENT COMPRISING PIPERIDINE DERIVATIVE AS ACTIVE COMPONENT | 2001 |
|
RU2275359C2 |
N-PHENYLARYLSULFONYLAMIDE, PHARMACEUTICAL COMPOSITION CONTAINING INDICATED SUBSTANCE AS ACTIVE COMPONENT, COMPOUND AS INTERMEDIATE IN SYNTHESIS OF INDICATED COMPOUND AND METHOD FOR ITS PREPARING | 2002 |
|
RU2299202C2 |
NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
COMPOUNDS BASED ON BENZOXAZINE AND INDOLE, WITH ANTAGONISTIC EFFECT ON cysLT RECEPTOR | 2004 |
|
RU2371436C2 |
NOVEL PYRIDINE DERIVATIVE AND DERIVATIVE OF PYRIMIDINE (3) | 2006 |
|
RU2362771C1 |
PEPTIDE COMPOUNDS | 2001 |
|
RU2281955C2 |
Authors
Dates
2017-05-12—Published
2012-09-27—Filed